Literature DB >> 9870136

Glucose intolerance, cognitive impairment and Alzheimer's disease.

M Vanhanen1, H Soininen.   

Abstract

The literature on cognitive function and Alzheimer's disease in non-insulin-dependent diabetes, impaired glucose tolerance and hyperinsulinaemia are briefly summarized. Neuropsychological, epidemilogical and endocrine contributions are reviewed, with an emphasis on the insulin hypothesis as a potential pathophysiological mechanism for Alzheimer's disease.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9870136     DOI： 10.1097/00019052-199812000-00011

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN： 1350-7540            Impact factor:   5.710


  12 in total

1.  The effect of glucose dose and fasting interval on cognitive function: a double-blind, placebo-controlled, six-way crossover study.

Authors:  Lauren Owen; Andrew B Scholey; Yvonne Finnegan; Henglong Hu; Sandra I Sünram-Lea
Journal:  Psychopharmacology (Berl)       Date:  2011-10-07       Impact factor: 4.530

Review 2.  Elevation of glutathione as a therapeutic strategy in Alzheimer disease.

Authors:  Chava B Pocernich; D Allan Butterfield
Journal:  Biochim Biophys Acta       Date:  2011-10-12

Review 3.  Redox proteomics in some age-related neurodegenerative disorders or models thereof.

Authors:  D Allan Butterfield; Hafiz Mohmmad Abdul; Shelley Newman; Tanea Reed
Journal:  NeuroRx       Date:  2006-07

4.  Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of age.

Authors:  Rukhsana Sultana; Renã A S Robinson; Fabio Di Domenico; Hafiz Mohmmad Abdul; Daret K St Clair; William R Markesbery; Jian Cai; William M Pierce; D Allan Butterfield
Journal:  J Proteomics       Date:  2011-06-25       Impact factor: 4.044

Review 5.  The negative effects of obesity and poor glycemic control on cognitive function: a proposed model for possible mechanisms.

Authors:  Michael L Alosco; John Gunstad
Journal:  Curr Diab Rep       Date:  2014-06       Impact factor: 4.810

Review 6.  Type 2 diabetes and risk of cognitive impairment and dementia.

Authors:  Rachel A Whitmer
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

Review 7.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

Review 8.  Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.

Authors:  D Allan Butterfield; Tanea Reed; Shelley F Newman; Rukhsana Sultana
Journal:  Free Radic Biol Med       Date:  2007-06-13       Impact factor: 7.376

9.  Caloric intake, dietary lifestyles, macronutrient composition, and alzheimer' disease dementia.

Authors:  Giulio Maria Pasinetti; Jun Wang; Shanee Porter; Lap Ho
Journal:  Int J Alzheimers Dis       Date:  2011-06-19

Review 10.  Diabetes Mellitus, Cognitive Impairment, and Traditional Chinese Medicine.

Authors:  S W Seto; G Y Yang; H Kiat; A Bensoussan; Y W Kwan; D Chang
Journal:  Int J Endocrinol       Date:  2015-04-28       Impact factor: 3.257
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.